AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,554,000 | +504.7% | 25,973 | +115.6% | 0.00% | – |
Q4 2018 | $257,000 | -74.7% | 12,046 | -53.1% | 0.00% | -100.0% |
Q3 2018 | $1,017,000 | +19.9% | 25,683 | +15.7% | 0.00% | 0.0% |
Q2 2018 | $848,000 | +232.5% | 22,195 | +161.9% | 0.00% | – |
Q1 2018 | $255,000 | – | 8,476 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |